Serum iron metabolism markers including hepcidin in multiple sclerosis patients
暂无分享,去创建一个
E. Eren | A. Yaman | H. Ellidağ | N. Yılmaz | O. Aydin | F. Kurtuluş | Aslı G Bayindir
[1] Bill Bynum,et al. Lancet , 2015, The Lancet.
[2] I. Sadowska-Bartosz,et al. Oxidative modification of serum proteins in multiple sclerosis , 2013, Neurochemistry International.
[3] C. Wolfson,et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review , 2013, BMC Neurology.
[4] Cris S Constantinescu,et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome , 2013, Multiple sclerosis.
[5] G. D’Angelo,et al. Role of hepcidin in the pathophysiology and diagnosis of anemia , 2013, Blood research.
[6] F. Salvi,et al. Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis , 2012, BMC Medical Genetics.
[7] Roberta J. Ward,et al. Brain iron metabolism and its perturbation in neurological diseases , 2011, Journal of Neural Transmission.
[8] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[9] F. Barkhof,et al. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency , 2010, Neurology.
[10] F. Salvi,et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. , 2010, International angiology : a journal of the International Union of Angiology.
[11] C. Guttmann,et al. Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[12] J. Stankiewicz,et al. Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.
[13] D. Girelli,et al. Immunoassay for human serum hepcidin. , 2008, Blood.
[14] L. Rashed,et al. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.
[15] D. Dexter,et al. Metal based neurodegenerative diseases - From molecular mechanisms to therapeutic strategies , 2008 .
[16] G. Giovannoni,et al. Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis , 2008, Multiple sclerosis.
[17] Rohit Bakshi,et al. Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.
[18] O. von Bohlen und Halbach,et al. Distribution of the iron‐regulating protein hepcidin in the murine central nervous system , 2006, Journal of neuroscience research.
[19] R. Bakshi,et al. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.
[20] C. W. Tjoa,et al. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.
[21] E. Hatzimichael,et al. Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients , 2005, Multiple sclerosis.
[22] J. Sullivan. Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.
[23] S. LeVine,et al. The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.
[24] C. Polman,et al. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. , 2002, Brain : a journal of neurology.
[25] P. Adam,et al. Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients , 2000, Acta neurologica Scandinavica.
[26] S. Lynch,et al. Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients , 1999, Brain Research.
[27] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[28] P. Sperryn,et al. Blood. , 1989, British journal of sports medicine.
[29] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[30] Manjit,et al. Neurology , 1912, NeuroImage.
[31] J. Winn,et al. Brain , 1878, The Lancet.
[32] Z. Qian,et al. Role of hepcidin in murine brain iron metabolism , 2009, Cellular and Molecular Life Sciences.